Codexis (CDXS) Total Liabilities (2010 - 2026)
Codexis (CDXS) recorded quarterly Total Liabilities of $86.1 million in Q1 2026, down 11.44% quarter-over-quarter from $97.3 million in Q4 2025, and up 8.68% on a YoY basis from $79.3 million in Q1 2025.
Codexis (CDXS) Total Liabilities (2010 - 2026) Analysis & Trends
Codexis' Total Liabilities history runs 17 years deep, the most recent figure standing at $86.1 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 8.68% year-over-year to $86.1 million; the TTM figure through Mar 2026 stood at $86.1 million (up 8.68% YoY), while the FY2025 annual figure was $97.3 million, up 18.5% from the prior year.
- Total Liabilities was $86.1 million for Q1 2026 at Codexis, down from $97.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $105.6 million in Q4 2022 to a low of $49.9 million in Q4 2023.
- Historically, Total Liabilities has averaged $79.7 million across 5 years, with a median of $81.2 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities slumped 52.7% in 2023, then soared 64.35% in 2024.
- A 5-year view of Total Liabilities shows it stood at $105.6 million in 2022, then plunged by 52.7% to $49.9 million in 2023, then soared by 64.35% to $82.1 million in 2024, then grew by 18.5% to $97.3 million in 2025, then retreated by 11.44% to $86.1 million in 2026.
- The last three Total Liabilities figures came in at $86.1 million (Q1 2026), $97.3 million (Q4 2025), and $85.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 137.56 Mn |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | 86.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.14 Mn |
| Dec 31, 2025 | 97.27 Mn |
| Sep 30, 2025 | 85.42 Mn |
| Jun 30, 2025 | 82.62 Mn |
| Mar 31, 2025 | 79.26 Mn |
| Dec 31, 2024 | 82.08 Mn |
| Sep 30, 2024 | 74.78 Mn |
| Jun 30, 2024 | 70.56 Mn |
| Mar 31, 2024 | 70.29 Mn |
| Dec 31, 2023 | 49.95 Mn |
| Sep 30, 2023 | 62.95 Mn |
| Jun 30, 2023 | 82.63 Mn |
| Mar 31, 2023 | 92.05 Mn |
| Dec 31, 2022 | 105.60 Mn |
| Sep 30, 2022 | 81.16 Mn |
| Jun 30, 2022 | 75.51 Mn |
| Mar 31, 2022 | 76.64 Mn |
| Dec 31, 2021 | 81.99 Mn |
| Sep 30, 2021 | 58.50 Mn |
| Jun 30, 2021 | 49.54 Mn |